3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
4
Multiple Myeloma
2
Vaccinia
1
Transplant-Related Hematologic Malignancy
1
Recurrence
1
Prostatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Medulloblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Hodgkin Disease
1
Glioma
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Azacitidine
10
Cyclophosphamide
9
venetoclax
7
fludarabine phosphate
7
fludarabine
6
Whole-Body Irradiation
6
Biopsy
6
Tacrolimus
5
Mycophenolic Acid
5
Injections
5
Decitabine
5
Busulfan
5
decitabine and cedazuridine drug combination
4
Specimen Handling
4
Peripheral Blood Stem Cell Transplantation
4
Cytarabine
4
cedazuridine
3
Stem Cell Transplantation
3
Cyclosporine
3
X-Rays
2
Vorinostat
2
Sirolimus
2
Rituximab
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
90 days
×
Clear all
No trials found.